关键信息
-
基因名
Streptavidin
- 应用
-
别名
Streptavidin
-
种属
Others
-
表达系统
E. coli
-
标签
Tag Free
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
分子量
14 kDa,based on SDS-PAGE under reducing conditions,112 kDa based on SDS-PAGE under non-reduced conditions,due to the glycosylation.
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
质检流程
相关产品
背景信息
Streptavidin is a tetrameric protein originally derived from the bacterium Streptomyces avidinii, known for its high affinity for biotin, a vitamin essential for various metabolic processes. The unique and robust interaction between streptavidin and biotin has made streptavidin an invaluable tool in biochemical research and biotechnology, particularly in applications such as biosensors, protein purification, and imaging techniques. The study of recombinant streptavidin employs techniques in molecular biology to produce this protein in yeast, bacteria, or mammalian cells, facilitating large-scale production and manipulation. Recombinant protein technology allows for the generation of streptavidin variants with tailored properties, including enhanced stability or altered binding characteristics. Additionally, research into the mechanisms underlying the streptavidin-biotin interaction has implications for drug design, vaccine development, and the development of new therapeutics, given its potential in targeted drug delivery systems. Overall, the investigation of recombinant streptavidin continues to expand its applicability in scientific research and industry, offering innovative solutions to complex biological challenges.
